Genetic Defect Identified in Infancy-Onset Diabetes

Article

Infants with permanent neonatal diabetes mellitus, a rare disorder presenting within six months of birth, have a genetic defect leading to misfolded proinsulins and cell death, according to a report in the May issue of the Journal of Clinical Investigation.

MONDAY, May 5 (HealthDay News) -- Infants with permanent neonatal diabetes mellitus (PNDM), a rare disorder presenting within six months of birth, have a genetic defect leading to misfolded proinsulins and cell death, according to a report in the May issue of the Journal of Clinical Investigation.

Carlo Colombo, from Bambino Gesu Children's Hospital, Scientific Institute in Rome, Italy, and colleagues sequenced the human insulin gene (INS) in 10 unrelated probands with PNDM or infancy-onset diabetes, noting that a mutation in the mouse counterpart is associated with PNDM and death of pancreatic beta-cells.

The researchers found seven heterozygous mutations in the INS gene. In eight patients, insulin secretion was initially detectable at the onset of diabetes but then rapidly declined. The mutant proinsulins were defective in protein folding and secretion, and cells expressing the mutant proinsulins had markers of endoplasmic reticulum stress and reduced viability.

"In conclusion, we find that mutations in the insulin gene that promote proinsulin misfolding may cause PNDM," Colombo and colleagues write.

AbstractFull Text

Copyright © 2008 ScoutNews, LLC. All rights reserved.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Recent Videos
Lori Handy, MD on importance of vaccine catch-up before the school year | Image credit: CHOP
Richard Wong, DO, explains challenges children with asthma face in school
Infectious Insights | Image Credit: Contemporary Pediatrics
John Browning, MD, provides practical skincare reminders ahead of summer season
Potential downstream benefits of RSV preventive measures, with Octavio Ramilo, MD
Discussing phase 3 data of Panzyga for PANS, with Michael Daines, MD
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
© 2025 MJH Life Sciences

All rights reserved.